pharmaphorum

JULY 28, 2022

billion on the back of strong demand for cough and cold remedies due to COVID-19. The performance of Dupixent and solid performances from its rare disease and consumer health divisions have allowed Sanofi to raise its forecasts (PDF) for earnings growth from low double-digits to 15%. Vaccine sales climbed 15% to €1.8

Sales 59

Sales FDA Medicine Leads 59

pharmaphorum

DECEMBER 15, 2022

RSV is one of the most common respiratory viruses, causing coughs and colds during the winter months. 2 Symptoms including congested or runny nose, coughing, fever, and sore throat mean that RSV can easily be mistaken for other respiratory viruses which are also prevalent during the same season, such as COVID-19 or flu.

Leads 69

Leads Medical Management Patients 69

PM360

JUNE 29, 2022

In December 2020, RB launched the Cough, Cold, and Flu Navigator with WebMD. The retailer has been gradually building out its network of in-store clinics—a bricks-and-mortar presence that will be complemented by its virtual care offering. Data can also play a role in connecting products to meet consumers’ needs in real-time.

Retail 97

Retail Healthcare Healthcare Marketing 97

European Pharmaceutical Review

NOVEMBER 21, 2022

The European Commission (EC) has granted marketing authorisation for Enjaymo ® ( sutimlimab ), as the only approved treatment of haemolytic anaemia in adults with cold agglutinin disease (CAD). CARDINAL study assessing Enjaymo ® for haemolytic anaemia patients with cold agglutinin disease. Headache (22.7 percent vs 10.0

Safety 105

Safety Patients Medical Management 105

Evolve Your Success

JANUARY 30, 2024

I was working in pharma, a pretty small company selling cough cold allergy medicine, and then made the transition. I stop in and talk to urgent care, family practice, dermatology here and there, and a pretty wide range of clinics. It’s your common cough cold allergy-type symptoms. Aaron, tell us.

Medical sales 52

Medical sales Sales Medical Pharma 52